Information management

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised

PSUSA/00002502/202503

Human medicines European public assessment report (EPAR): Puregon, follitropin beta, Date of authorisation: 02/05/1996, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Fetcroja, cefiderocol, Date of authorisation: 23/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): RotaTeq, rotavirus vaccine, live, Date of authorisation: 26/06/2006, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Orgalutran, ganirelix, Date of authorisation: 16/05/2000, Revision: 26, Status: Authorised

EMA - European Consumer Organisation (BEUC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 10 November 2025

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 30, Status: Authorised